HAEMONETICS CORP — Director's Dealing 2017

Jul 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-07-27

Reporting Person: BURZIK CATHERINE M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-27	Common Stock	A	4329	$39.27	Acquired	8599	Direct

Footnotes

F1: Restricted Stock Unit grant which vests 100% on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.